Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lars Wick
Observed name:
L Wick
Institution:
University of Colorado Anschutz
Observed institution:
University of Colorado Anschutz
ORCID:
0009-0008-3479-8053
Observed ORCID:
0009-0008-3479-8053
OpenAlex ID:
A5116160866
Cryo-EM structures reveal the PP2A–B55α and Eya3 interaction that can be disrupted by a peptide inhibitor
2025
·
Shasha Shi
, Xueni Li
, et al.
·
Journal of Biological Chemistry
·
2
Abstract B005: Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit
2026
·
Brian Abraham
, Annika Gustafson
, et al.
·
Cancer Research
Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit
2026
·
AL Gustafson
, S Nance
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Genetic and Pharmacologic Targeting of Eya3 in Macrophages Drives Anti-Tumor Immunity in Triple-Negative Breast Cancer
2026
·
Kaiah M. Fields
, Gabriela Terue Rizzo Kodama
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
Abstract 3500: Synergistic targeting of EP300/CBP and EYA co-activators collapses the rhabdomyosarcoma core regulatory circuit
2026
·
Annika Gustafson
, Stephanie Nance
, et al.
·
Cancer Research
Show more works
View as search
Works count:
5
Citation count:
2
H-index:
1
I10-index:
Year
Topic
Type